Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

It's been more than a year since the Food and Drug Administration approved the first vaccine to treat RSV. Since then, newly ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

The Respiratory Syncytial Virus (RSV) vaccine will be rolled out to some older islanders as well as pregnant women. | ITV ...